SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-14-069949
Filing Date
2014-11-20
Accepted
2014-11-20 09:35:31
Documents
1
Period of Report
2014-11-18

Document Format Files

Seq Description Document Type Size
1 form471638_20141120093430-.html 4  
1 form471638_20141120093430-.xml 4 4814
  Complete submission text file 0001144204-14-069949.txt   6379
Mailing Address 721 ROUTE 202/206, SUITE 130 BRIDGEWATER NJ 08807
Business Address 721 ROUTE 202/206, SUITE 130 BRIDGEWATER NJ 08807 908-864-4444
Sevion Therapeutics, Inc. (Issuer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services

Mailing Address P.O. BOX 5350 PRINCETON NJ 08543-5350
Business Address
Browne Leslie J (Reporting) CIK: 0001300293 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31326 | Film No.: 141237718